Labedipinedilol-A: A vanilloid-based α/β-adrenoceptor blocker with calcium entry blocking and long-acting antihypertensive properties

Jhy Chong Liang, Jwu Lai Yeh, Lien Chai Chiang, Yu Chiao Yang, Sheng Hsiung Sheu, Wen Ter Lai, Ing Jun Chen*


研究成果: 雜誌貢獻期刊論文同行評審

17 引文 斯高帕斯(Scopus)


The combination of β-adrenoceptor blockade and vasodilator action have proved highly useful in antihypertensive therapy. Studies of the mechanisms of action of labedipinedilol-A that combine these effects within a single molecule are described in this report. Intravenous labedipinedilol-A (0.1-1.0 mg/kg) produced dose-dependent hypotensive and bradycardia responses for above 1.0 h, significantly different from nifedipine (0.5 mg/kg, i.v.)- induced hypotensive and reflex tachycardia activities in pentobarbital- anesthetized Wistar rats. Pretreatment with labedipinedilol-A also inhibited phenylephrine (20 μg/kg, i.v.)-induced hypertensive and (-)isoprenaline (0.5 μg/kg, i.v.)-induced tachycardia effects. Oral administration of labedipinedilol-A (5-50 mg/kg) in spontaneously hypertensive rats (SHR) reduced the blood pressure and heart rate for 24 h but did not increase heart rate. Labedipinedilol-A (10-7 -10-5 M) competitively antagonized (- )isoprenaline (10-10-10-4M)-induced positive chronotropic and inotropic effects of the isolated rat atria and tracheal relaxation responses of the isolated guinea pig tissues. Labedipinedilol-A also prevented the rate- increasing effects of increased extracellular Ca2+ (3.0-9.0 mM) in a concentration-dependent manner. In the isolated rat aorta, labedipinedilol-A competitively antagonized CaCl2 and norepinephrine-induced contractions with pKCa-1 and pA2 values of 8.46 ± 0.05 and 8.28 ± 0.03 and had a potent effect of inhibiting high K+ -induced vasocontraction. Furthermore, labedipinedilol-A, in an equal antagonist activity, inhibited norepinephrine- induced phasic and tonic contraction. In the cultured blood vessel smooth muscle cell (A7r5 cell line), KCl, norepinephrine, and Bay K 8644-induced intracellular calcium changes were decreased after application of labedipinedilol-A (10-9-10-6 M). The binding characteristics of labedipinedilol-A were evaluated in [3H]CGP-12177 binding to ventricle and lung and [3H]nitrendipine and [3H]prazosin binding to brain membranes in rats. The -logIC50 values of labedipinedilol-A for β1-, β2-, and α1- adrenoceptor and calcium channel, were 8.17 x 10-7 M, 8.20 x 10-7 M, 2.20 x 10-8 M, and 2.46 x 10-8 M, respectively. Labedipinedilol-A-induced sustained depressor effect was mainly attributed to its calcium entry and α- adrenoceptor blocking activities in the blood vessel. Sustained bradycardia effect resulted from β-adrenoceptor and calcium entry blocking, which deleted the sympathetic activation-associated reflex tachycardia in the heart. (C) 2000 Wiley-Liss, Inc.

頁(從 - 到)94-108
期刊Drug Development Research
出版狀態已發佈 - 2000

ASJC Scopus subject areas

  • 藥物發現


深入研究「Labedipinedilol-A: A vanilloid-based α/β-adrenoceptor blocker with calcium entry blocking and long-acting antihypertensive properties」主題。共同形成了獨特的指紋。